Viewing StudyNCT03286842



Ignite Creation Date: 2024-05-06 @ 10:33 AM
Last Modification Date: 2024-10-26 @ 12:31 PM
Study NCT ID: NCT03286842
Status: COMPLETED
Last Update Posted: 2023-01-17
First Post: 2017-08-17

Brief Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
HER2-ve Metastatic Breast Cancer
Germline BRCA12 Mutations
Somatic BRCA12 Mutations
Keywords:
Name View
BRCA2 View
HER2-ve metastatic breast cancer View
Germline BRCA12 mutations View
Somatic BRCA12 mutations View
BRCA1 View